Home - Products - Others - Other Targets - Octyl 3-(4-hydroxyphenyl)prop-2-enoate

Octyl 3-(4-hydroxyphenyl)prop-2-enoate

CAS No. ———

Octyl 3-(4-hydroxyphenyl)prop-2-enoate( ——— )

Catalog No. M39161 CAS No. ———

Octyl 3-(4-hydroxyphenyl)prop-2-enoate

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Octyl 3-(4-hydroxyphenyl)prop-2-enoate
  • Note
    Research use only, not for human use.
  • Brief Description
    Octyl 3-(4-hydroxyphenyl)prop-2-enoate
  • Description
    Octyl 3-(4-hydroxyphenyl)prop-2-enoate
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    ———
  • Formula Weight
    276.4
  • Molecular Formula
    C17H24O3
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Sodium D-lactate

    Lactic acid is an organic acid. It is a chiral molecule consisting of two optical isomers L-lactic acid and D-lactic acid with the L-isomer being the most common in living organisms. Lactic acid also is a microbial metabolite.

  • Gossypetin 3-sophoro...

    Gossypetin 3-sophoroside-7-glucoside

  • PAR-3 (1-6) (human)

    PAR3 (1-6) is a synthetic peptide agonist of proteinase-activated receptor 1 (PAR1) that corresponds to residues 1-6 of the amino terminal tethered ligand sequence of human PAR3 and residues 39-44 of the full-length human sequence. PAR3 (1-6) activates p42/44 MAPK signaling in fibroblasts expressing PAR1, but not PAR3, an effect that can be blocked by the PAR1 antagonist RWJ 56110.